NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Healthcare

ABBOTT INTRODUCES JOT DX™ INSERTABLE CARDIAC MONITOR, DESIGNED TO REDUCE DATA BURDEN AND IMPROVE ACCURATE DIAGNOSIS OF DIFFICULT-TO-DETECT ABNORMAL HEART RHYTHMS

by Ed Johnson
July 30, 2021
A A

– Jot Dx™ Insertable Cardiac Monitor (ICM) expands Abbott’s connected care portfolio and is the first and only device on the market with the option to control the amount of electronic data received for irregular heart rhythms, depending on the unique needs of the patient or clinic

– Jot Dx™ ICM connects via Bluetooth with Abbott’s myMerlin™ mobile app for continuous remote monitoring, leading to a faster time to diagnosis compared to ICMs that may use traditional bedside monitors1

– Abbott’s personalized concierge service, SyncUp™, provides one-on-one device setup support, helping patients connect Jot Dx™ ICM with the mobile app at home, taking the burden off physicians and clinic staff

Abbott today announced the U.S. launch of Jot Dx™, the company’s latest insertable cardiac monitor (ICM). The Jot Dx™ ICM gives clinicians and hospitals control of how they manage the flow of information through a unique feature to view either all abnormal heart rhythm data or to simplify which irregular heart rhythms are recorded with a “key episodes” option. This technology allows for remote detection and improved diagnosis accuracy of cardiac arrythmia in patients. Jot Dx™ ICM is supported by SyncUP™, a personalized service that delivers one-on-one training and education to help patients get connected and stay connected to their ICM.

An arrhythmia is an abnormal heart rhythm that develops when disease or injury disrupts the heart’s electrical signals, causing the heart to beat erratically. As a result, arrhythmias can lead to symptoms such as palpitations, dizziness, shortness of breath or fainting. The most common arrhythmia is atrial fibrillation, or AFib, which is projected to impact more than half of the worldwide population by 2050.2

“Over the past year, there has been an increased focus on telehealth and connected care technology. This has provided access to more data, adding to the time needed to assess patients thoroughly,” said John Costello, D.O., Electrophysiology at The Heart House, Marlton, New Jersey. “With the Jot Dx key episodes option, the ability to distil information is a distinct, time-saving enhancement that helps care teams make important, life-saving clinical care decisions faster.”

Leveraging the Potential of Connected Care

To better help physicians diagnose their patients’ abnormal heart rhythms, Jot Dx™ ICM continuously monitors patient cardiac rhythms 24 hours a day, 7 days a week and connects directly to myMerlin™, a downloadable mobile app that transmits data in real-time to both the clinician and patient. For the first time in an ICM, Jot provides clinicians increased control over patient monitoring, with an option to toggle between viewing only three key episodes or all episodes depending on individual patient needs to make and accurate diagnosis. This functionality reduces overall data burden. For example, for every 100 patients, it can save clinic staff up to 120 hours per month in reviewing electromyogram (EGM) transmissions3 while also providing the flexibility needed to find hard-to-detect arrhythmias.

In addition to improving workflow for physicians, clinics and health systems monitoring patients with potential abnormal heart rhythms, Abbott is also improving how patients interact with their device. A key element in the setup of Jot Dx™ ICM and the myMerlin™ mobile app is the new SyncUP™ support service, which Abbott offers on select products as part of its connected care portfolio. With SyncUP™, an Abbott support expert will enroll a patient with a newly implanted device in the system, orient them through getting to know their new heart monitoring device and confirm connection to the myMerlin™ app.

SyncUP™ is designed to educate people about the technology from the comfort of home, which has been shown to increase information retention and encourage compliance4, and helps reduce in-clinic burden. Currently, the process to ensure a patient is connected is conducted in the healthcare facility directly following the device’s implant, which prolongs the stay for the patient. SyncUP™ also support patients with Abbott’s implantable defibrillator, Gallant™ ICD.

Once connected, clinicians can monitor patients remotely, allowing for identification of asymptomatic episodes, as well as patient-triggered transmissions, which can lead to earlier intervention. Remote monitoring can shorten the time for doctors to diagnosis and make a care decision, if needed.5,6

“Technology can be intimidating, particularly when your heart is relying on it,” said Heidi Hinrichs, divisional vice president of global clinical and regulatory for Abbott’s Cardiac Rhythm Management business. “With Jot Dx™ ICM, myMerlin™, SyncUP™ and our other technologies, we want people to feel supported, knowledgeable and confident when using them, and ultimately, in control of their care. We understand healthcare is not one-size-fits-all and have learned from the people who use our products that a patient-centric approach can lead to a more manageable heart health experience.”

Tags: < Corporate Events
ShareTweetShareSend

Related Industries

Healthcare

Medtronic recommends rejection of below-market mini-tender offer by TRC Capital Investment Corporation

January 26, 2023
Healthcare

Johnson & Johnson Reports Q4 and Full-Year 2022 Results

January 25, 2023
Healthcare

Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries

January 18, 2023
Healthcare

AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets

January 11, 2023
Healthcare

Baxter Announces Strategic Actions to Enhance Operational Effectiveness, Accelerate Innovation for Patients and Drive Value for Shareholders

January 7, 2023
Healthcare

Michelle Quinn Named Acting General Counsel for BD

January 7, 2023

UC Investments Creates Strategic Venture with Blackstone to Invest $4 Billion in BREIT Common Shares

January 4, 2023

...

Bristol Myers Squibb Completes Sale of Manufacturing Facility in Syracuse, New York

January 4, 2023

...

Dow named one of America’s most JUST Companies for the fourth year by JUST Capital

Dow named one of America’s most JUST Companies for the fourth year by JUST Capital

January 11, 2023

...

Ford’s John Savona to Retire in March, Closing 33-Year Career; Bryce Currie Will Lead Americas Manufacturing, Labor Affairs

January 12, 2023

...

Mark Parker To Be Named Chairman Of The Walt Disney Company

January 12, 2023

...

Hilton Unveils New Brand, Spark by Hilton, a Value‑Driven Offering That Proudly Delivers Reliable Essentials and Friendly Service

January 12, 2023

...

chevron finalizes acquisition of beyond6 CNG fueling network

January 4, 2023

...

AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets

January 11, 2023

...

BASF breaks ground on MDI capacity expansion project at Geismar site

January 12, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

INDUSTRIES

  • Aero
  • Agriculture
  • ALL
  • Automotive
  • Business Service
  • Chemical
  • Construction
  • Construction Materials
  • Consumer
  • Education
  • Energy
  • Entertainment
  • Environmental
  • F&B
  • Financial
  • Healthcare
  • Hospitality
  • Industrial
  • IT
  • IT Hardware
  • Logistic
  • Metal & Mining
  • Packaging & Paper
  • Rail
  • Real Estate
  • Telecom

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NA-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NA-BIZ.COM All rights reserved.